The Fort Worth Press - Boomerang Ventures Portfolio Company Respiratory Health Technologies Secures Seed Capital to Accelerate Growth in Respiratory Wellness

USD -
AED 3.67315
AFN 62.000368
ALL 81.51445
AMD 371.778334
ANG 1.789884
AOA 918.000367
ARS 1397.72412
AUD 1.399776
AWG 1.8
AZN 1.70397
BAM 1.67081
BBD 2.013677
BDT 122.673182
BGN 1.668102
BHD 0.377288
BIF 2967
BMD 1
BND 1.277134
BOB 6.908482
BRL 5.008304
BSD 0.999748
BTN 94.17433
BWP 13.541889
BYN 2.832162
BYR 19600
BZD 2.010772
CAD 1.36795
CDF 2315.000362
CHF 0.784904
CLF 0.022741
CLP 895.040396
CNY 6.836304
CNH 6.83428
COP 3564.14
CRC 454.982295
CUC 1
CUP 26.5
CVE 94.37504
CZK 20.777504
DJF 177.720393
DKK 6.375104
DOP 59.47504
DZD 132.47904
EGP 52.572403
ERN 15
ETB 154.557616
EUR 0.85304
FJD 2.20465
FKP 0.741029
GBP 0.73888
GEL 2.68504
GGP 0.741029
GHS 11.103856
GIP 0.741029
GMD 73.503851
GNF 8777.503848
GTQ 7.643154
GYD 209.167133
HKD 7.83565
HNL 26.566831
HRK 6.42904
HTG 130.89126
HUF 311.520388
IDR 17252.7
ILS 2.98605
IMP 0.741029
INR 94.065604
IQD 1310
IRR 1317000.000352
ISK 122.670386
JEP 0.741029
JMD 157.781204
JOD 0.70904
JPY 159.36604
KES 129.330385
KGS 87.403204
KHR 4010.00035
KMF 420.00035
KPW 900.025942
KRW 1476.640383
KWD 0.30776
KYD 0.83317
KZT 464.413397
LAK 21950.000349
LBP 89550.000349
LKR 318.684088
LRD 184.000348
LSL 16.510381
LTL 2.95274
LVL 0.60489
LYD 6.345039
MAD 9.25038
MDL 17.386104
MGA 4154.297601
MKD 52.595879
MMK 2099.863185
MNT 3580.436774
MOP 8.068154
MRU 39.980379
MUR 46.870378
MVR 15.450378
MWK 1736.000345
MXN 17.37935
MYR 3.965039
MZN 63.910377
NAD 16.510377
NGN 1357.000344
NIO 36.793255
NOK 9.317039
NPR 150.678928
NZD 1.70097
OMR 0.38415
PAB 0.999748
PEN 3.466357
PGK 4.339785
PHP 60.695038
PKR 278.710741
PLN 3.619704
PYG 6339.538182
QAR 3.644635
RON 4.341604
RSD 100.194531
RUB 75.185839
RWF 1461.31438
SAR 3.750923
SBD 8.048583
SCR 13.737781
SDG 600.503676
SEK 9.220372
SGD 1.276038
SHP 0.746601
SLE 24.603667
SLL 20969.496166
SOS 571.335822
SRD 37.463504
STD 20697.981008
STN 20.929527
SVC 8.747726
SYP 110.562389
SZL 16.510369
THB 32.340369
TJS 9.39787
TMT 3.505
TND 2.919455
TOP 2.40776
TRY 45.007504
TTD 6.789739
TWD 31.462038
TZS 2602.503628
UAH 44.056743
UGX 3719.475993
UYU 39.60396
UZS 12011.891439
VES 482.733725
VND 26359
VUV 117.829836
WST 2.712269
XAF 560.364432
XAG 0.013194
XAU 0.000212
XCD 2.70255
XCG 1.801819
XDR 0.696601
XOF 560.385974
XPF 101.880248
YER 238.625037
ZAR 16.534405
ZMK 9001.203584
ZMW 18.920373
ZWL 321.999592
  • RBGPF

    63.0000

    63

    +100%

  • CMSC

    0.0400

    22.95

    +0.17%

  • CMSD

    0.0900

    23.32

    +0.39%

  • NGG

    0.4600

    87.42

    +0.53%

  • RIO

    0.7600

    99.61

    +0.76%

  • GSK

    -1.1900

    54.44

    -2.19%

  • BCC

    0.3300

    84.15

    +0.39%

  • RELX

    0.4000

    36.53

    +1.09%

  • JRI

    0.0100

    12.89

    +0.08%

  • BCE

    -0.2200

    23.88

    -0.92%

  • RYCEF

    -0.1900

    15.35

    -1.24%

  • BTI

    0.8100

    58.09

    +1.39%

  • VOD

    0.0100

    15.63

    +0.06%

  • AZN

    -2.5500

    189.75

    -1.34%

  • BP

    -0.1000

    46.25

    -0.22%

Boomerang Ventures Portfolio Company Respiratory Health Technologies Secures Seed Capital to Accelerate Growth in Respiratory Wellness
Boomerang Ventures Portfolio Company Respiratory Health Technologies Secures Seed Capital to Accelerate Growth in Respiratory Wellness

Boomerang Ventures Portfolio Company Respiratory Health Technologies Secures Seed Capital to Accelerate Growth in Respiratory Wellness

Aims to Disrupt $11B Wellness and Respiratory Health Market

Text size:

INDIANAPOLIS, IN, NY / ACCESS Newswire / October 9, 2025 / Boomerang Ventures today announced that portfolio company Respiratory Health Technologies has successfully closed its seed financing round, marking a significant milestone for both the Boomerang Studio and Boomerang Fund. The investment round was led by Wellington Group Ventures, with participation from Boomerang VC Fund I, LP, underscoring the strength of Boomerang's integrated studio-fund model in advancing connected health innovations.

Respiratory Health Technologies, an Indianapolis-based respiratory wellness company, is pioneering a new approach to sinus health with SinuSauna®, the first doctor-invented at-home respiratory wellness device that uses heated dry-air therapy-rather than steam or saline to relieve congestion naturally. Since its national debut in 2024, SinuSauna has gained traction among consumers seeking safe, effective, and drug-free solutions for their sinus care needs.

A Milestone for Boomerang's Studio-Fund Model

The completion of Respiratory Health Technologies' seed financing reflects the success of Boomerang's unique approach, which combines a venture studio with a venture fund to accelerate healthcare innovation.

"Respiratory Health Technologies' seed raise is a powerful validation of the Boomerang model," said Eric Beier, MD, Partner and Chief Medical Officer of Boomerang Ventures. "Through the structured derisking and business building in our venture studio matched with pre-seed and seed funding from our venture fund, we've helped Respiratory Health Technologies bring an innovative product to market and secure the capital needed to scale. This achievement demonstrates how an integrated approach can accelerate solutions that make a real impact in healthcare."

Fueling Growth and Expanding Access

The seed funding will enable Respiratory Health Technologies to expand market presence, drive product development, and build national brand awareness in the $11B respiratory wellness market. Nearly 50% of Americans suffer from nasal congestion, underscoring the vast and ongoing need for effective solutions.

"Closing this round allows us to build on our momentum and provides a real opportunity to disrupt the respiratory wellness space by delivering drug-free sinus relief to more people than ever before," said Nancy Wright, CEO and Co-Founder of Respiratory Health Technologies. "Boomerang's partnership has been instrumental in helping us move from idea to commercialization.

Investor Support

"Wellington Group Ventures seeks out companies with defensible innovation and the ability to execute at scale," said Tony Bonanno, Managing member at Wellington Group Ventures. "Respiratory Health Technologies is exactly that - a team with vision, a patent-protected solution, and momentum in a large and expanding market. We are excited to support their long-term growth journey."

About Boomerang Ventures

Founded in 2019, Boomerang Ventures is a venture capital firm focused on early growth-stage connected health technology companies. Leveraging a combination studio and venture fund, Boomerang provides the collaborative direction, deep industry expertise, and continuum of support founders need to take their innovations from ideation to market. Boomerang believes that better patient care begins with identifying and solving the biggest challenges in healthcare. Boomerang Ventures is proudly and strategically based in Indianapolis, where the healthcare and entrepreneurial business climate is a thriving community ripe with opportunities. With a secure niche at the intersection of health technology, studio-fund synchronization, and the Midwest, Boomerang differentiates itself from the competition. Boomerang Ventures is Healthcare Innovation, Reimagined. For more information, visit Boomerang.vc.

About Respiratory Health Technologies

Respiratory Health Technologies is an Indianapolis-based wellness CPG company dedicated to developing innovative, drug-free solutions for respiratory care. Its flagship product, SinuSauna, combines medical insight with user-focused design to help people breathe better, naturally. Learn more at sinusauna.com.

About Wellington Group Ventures

Wellington Group Ventures is the venture capital arm of The Wellington Group. Founded in 1996, The Wellington Group is a boutique wealth management firm dedicated to aligning financial strategies with each client's unique purpose. Serving individuals, families, business owners, and high-net-worth clients, the firm specializes in retirement planning, tax efficiency, legacy building, and business succession. Proudly based in Indianapolis, The Wellington Group combines deep expertise with a personalized approach, helping clients navigate complexity and live with financial confidence. For more information, visit thewellingtongroupllc.com.

# # #

Media Contact:
Audra Wait | Wait & Co. on behalf of Boomerang Ventures
[email protected] | 615.504.8812

SOURCE: Boomerang Ventures



View the original press release on ACCESS Newswire

S.Rocha--TFWP